|
CNOT3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.839600E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.122870E-03 |
| Normal-vs-Stage2 |
1.159590E-01 |
| Normal-vs-Stage3 |
3.147900E-02 |
| Normal-vs-Stage4 |
1.335910E-02 |
| Stage1-vs-Stage2 |
5.361400E-01 |
| Stage1-vs-Stage3 |
5.172600E-01 |
| Stage1-vs-Stage4 |
9.254600E-01 |
| Stage2-vs-Stage3 |
8.999400E-01 |
| Stage2-vs-Stage4 |
6.338200E-01 |
| Stage3-vs-Stage4 |
6.781000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.119300E-03 |
| Normal-vs-AfricanAmerican |
3.831100E-04 |
| Normal-vs-Asian |
1.011920E-04 |
| Caucasian-vs-AfricanAmerican |
2.875800E-02 |
| Caucasian-vs-Asian |
1.017750E-02 |
| AfricanAmerican-vs-Asian |
1.236830E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.588500E-02 |
| Normal-vs-Female |
2.27189999999489E-05 |
| Male-vs-Female |
8.181800E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.098200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.046600E-04 |
| Normal-vs-Age(61-80Yrs) |
5.823200E-03 |
| Normal-vs-Age(81-100Yrs) |
6.854800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.589200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.808800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.565000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.447000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.211440E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.755200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.19910000209822E-08 |
| Normal-vs-Grade 2 |
2.895400E-03 |
| Normal-vs-Grade 3 |
3.028200E-02 |
| Normal-vs-Grade 4 |
7.744100E-03 |
| Grade 1-vs-Grade 2 |
1.34409999996699E-06 |
| Grade 1-vs-Grade 3 |
2.50669999979358E-07 |
| Grade 1-vs-Grade 4 |
3.07050000003528E-06 |
| Grade 2-vs-Grade 3 |
2.399000E-01 |
| Grade 2-vs-Grade 4 |
7.885200E-01 |
| Grade 3-vs-Grade 4 |
2.915000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.223240E-03 |
| Normal-vs-ccB subtype |
3.992200E-02 |
| ccA subtype-vs-ccB subtype |
2.562000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.175600E-03 |
| Normal-vs-N1 |
3.692100E-02 |
| N0-vs-N1 |
5.555400E-01 |
|
|
